newsfilter
← Latest News
Business Wire·

4D pharma plc ("4D pharma") Receives Notice of Delisting From Nasdaq

4D pharma plc ((AIM: DDDD, NASDAQ:LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from T